Evidence supporting the use of: Grape
For the health condition: Dementia

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Grapes, particularly the compounds found in grape skins and seeds such as resveratrol and polyphenols, have been studied for their potential neuroprotective effects, including possible benefits for dementia and cognitive decline. Some scientific research, primarily in animal models and small human studies, suggests that these compounds may help reduce oxidative stress and inflammation in the brain, mechanisms implicated in dementia pathogenesis. Resveratrol, in particular, has been shown to cross the blood-brain barrier and may exert beneficial effects on brain health by modulating pathways related to amyloid-beta accumulation and neuroinflammation.

However, the clinical evidence in humans remains limited and mixed. Some small-scale clinical trials have reported modest improvements in cognitive function or biomarkers related to Alzheimer's disease after supplementation with grape-derived polyphenols or resveratrol. For example, a 2015 randomized controlled trial found that resveratrol stabilized certain biomarkers in patients with mild to moderate Alzheimer's disease, though cognitive benefits were minimal. Other studies have failed to demonstrate significant cognitive improvement. Importantly, no large-scale, long-term clinical trials have established grape or its constituents as effective treatments for dementia.

In summary, while there is a scientific rationale and some preliminary evidence supporting the use of grape-derived compounds for dementia, the current level of evidence is insufficient to recommend their use as a primary treatment. More robust clinical research is needed to clarify their efficacy and safety for this purpose.

More about grape
More about Dementia